Home Site Map Privacy

 
Search this Site
 
 
 
 
 


Isao Teshirogi
President and
Representative Director
Shionogi & Co., Ltd.

   
 

History of Shionogi & Co., Ltd.

Shionogi & Co., Ltd. traces it’s history back to 1878, when Gisaburo Shiono founded a drug wholesaling business in Osaka, Japan. Over time, Shionogi has evolved into one of today’s leading Japanese pharmaceutical companies, centered around the corporate mission to “constantly strive to provide superior medicine essential to people’s health”. Shionogi’s core business is ethical pharmaceuticals, particularly in the fields of infectious diseases, cardiovascular and metabolic diseases, and cancer and related chronic pain.
Key Events

1878 -- Gisaburo Shiono founded drug wholesaling business
1892 -- Shionogi began manufacturing chemicals
1909 -- First pharmaceutical product, Antacidin, was launched
1949 -- Stocks were listed on Security Exchange of Tokyo and Osaka
1963 -- Started businesses in animal health, agricultural chemicals, and clinical
laboratory testing
1978 -- 100th anniversary
1992 -- Acquired capsule business from Eli Lilly & Co
2001 -- Established Shionogi USA; divested agricultural chemicals business
2002 -- Divested animal health and clinical testing businesses to intensify focus on ethical pharmaceuticals
2004 -- Shionogi acquires US marketing and distribution rights for CEDAX®